🚀 VC round data is live in beta, check it out!
Quest Diagnostics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Quest Diagnostics and similar public comparables like Sartorius, Labcorp, Exact Sciences, Mettler Toledo and more.
Quest Diagnostics Overview
About Quest Diagnostics
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Founded
1990
HQ
Employees
56.0K
Website
Financials (LTM)
EV
$28B
Quest Diagnostics Financials
Quest Diagnostics reported last 12-month revenue of $11B and EBITDA of $2B.
In the same LTM period, Quest Diagnostics generated $4B in gross profit, $2B in EBITDA, and $1B in net income.
Revenue (LTM)
Quest Diagnostics P&L
In the most recent fiscal year, Quest Diagnostics reported revenue of $11B and EBITDA of $2B.
Quest Diagnostics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $11B | XXX | $11B | XXX | XXX | XXX |
| Gross Profit | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Margin | 33% | XXX | 33% | XXX | XXX | XXX |
| EBITDA | $2B | XXX | $2B | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $1B | XXX | $1B | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Quest Diagnostics Stock Performance
Quest Diagnostics has current market cap of $22B, and enterprise value of $28B.
Market Cap Evolution
Quest Diagnostics' stock price is $195.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $28B | $22B | 0.0% | XXX | XXX | XXX | $10.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQuest Diagnostics Valuation Multiples
Quest Diagnostics trades at 2.5x EV/Revenue multiple, and 12.4x EV/EBITDA.
EV / Revenue (LTM)
Quest Diagnostics Financial Valuation Multiples
As of April 19, 2026, Quest Diagnostics has market cap of $22B and EV of $28B.
Equity research analysts estimate Quest Diagnostics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Quest Diagnostics has a P/E ratio of 18.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $22B | XXX | $22B | XXX | XXX | XXX |
| EV (current) | $28B | XXX | $28B | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | 12.4x | XXX | 12.7x | XXX | XXX | XXX |
| EV/EBIT | 15.4x | XXX | 15.8x | XXX | XXX | XXX |
| EV/Gross Profit | 7.4x | XXX | 7.6x | XXX | XXX | XXX |
| P/E | 18.9x | XXX | 19.3x | XXX | XXX | XXX |
| EV/FCF | 21.3x | XXX | 20.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Quest Diagnostics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Quest Diagnostics Margins & Growth Rates
Quest Diagnostics' revenue in the last 12 month grew by 6%.
Quest Diagnostics' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Quest Diagnostics' rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Quest Diagnostics' rule of X is 37% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Quest Diagnostics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Quest Diagnostics Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Quest Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sartorius | XXX | XXX | XXX | XXX | XXX | XXX |
| Labcorp | XXX | XXX | XXX | XXX | XXX | XXX |
| Exact Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Mettler Toledo | XXX | XXX | XXX | XXX | XXX | XXX |
| Eurofins Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Quest Diagnostics M&A Activity
Quest Diagnostics acquired XXX companies to date.
Last acquisition by Quest Diagnostics was on XXXXXXXX, XXXXX. Quest Diagnostics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Quest Diagnostics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialQuest Diagnostics Investment Activity
Quest Diagnostics invested in XXX companies to date.
Quest Diagnostics made its latest investment on XXXXXXXX, XXXXX. Quest Diagnostics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Quest Diagnostics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Quest Diagnostics
| When was Quest Diagnostics founded? | Quest Diagnostics was founded in 1990. |
| Where is Quest Diagnostics headquartered? | Quest Diagnostics is headquartered in United States. |
| How many employees does Quest Diagnostics have? | As of today, Quest Diagnostics has over 56K employees. |
| Who is the CEO of Quest Diagnostics? | Quest Diagnostics' CEO is James E. Davis. |
| Is Quest Diagnostics publicly listed? | Yes, Quest Diagnostics is a public company listed on NYSE. |
| What is the stock symbol of Quest Diagnostics? | Quest Diagnostics trades under DGX ticker. |
| When did Quest Diagnostics go public? | Quest Diagnostics went public in 1996. |
| Who are competitors of Quest Diagnostics? | Quest Diagnostics main competitors are Sartorius, Labcorp, Exact Sciences, Mettler Toledo. |
| What is the current market cap of Quest Diagnostics? | Quest Diagnostics' current market cap is $22B. |
| What is the current revenue of Quest Diagnostics? | Quest Diagnostics' last 12 months revenue is $11B. |
| What is the current revenue growth of Quest Diagnostics? | Quest Diagnostics revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Quest Diagnostics? | Current revenue multiple of Quest Diagnostics is 2.5x. |
| Is Quest Diagnostics profitable? | Yes, Quest Diagnostics is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Quest Diagnostics? | Quest Diagnostics' last 12 months EBITDA is $2B. |
| What is Quest Diagnostics' EBITDA margin? | Quest Diagnostics' last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Quest Diagnostics? | Current EBITDA multiple of Quest Diagnostics is 12.4x. |
| What is the current FCF of Quest Diagnostics? | Quest Diagnostics' last 12 months FCF is $1B. |
| What is Quest Diagnostics' FCF margin? | Quest Diagnostics' last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Quest Diagnostics? | Current FCF multiple of Quest Diagnostics is 21.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.